In a compelling convergence of ancient herbalism and modern geroprotection, researchers have demonstrated that a simple water extract of Licorice (Glycyrrhiza uralensis) can significantly reverse signs of biological aging in a mouse model. The study, published in Mediators of Inflammation, suggests that this common botanical does not merely act as an antioxidant; it functions as a caloric restriction mimetic by downregulating the PI3K/AKT/mTOR signaling pathway in the brain.
The mammalian target of rapamycin (mTOR) is the “master switch” of cellular growth. When overactive, it drives aging; when suppressed (as by fasting or the drug rapamycin), it extends lifespan. This study found that Licorice Water (LW) extract effectively “cooled down” this overactive pathway in D-galactose-induced aging mice, leading to preserved hippocampal structure, improved cognition, and a reversal of systemic frailty. Furthermore, the extract remodeled the gut microbiome, correcting the “dysbiosis of aging” by reducing the Firmicutes-to-Bacteroidetes ratio—a classic marker of metabolic health often lost in old age.
While the results are promising, the study utilizes the D-galactose “accelerated aging” model rather than natural aging, which limits direct translation to human longevity. However, the dual-action mechanism—simultaneously dampening central mTOR signaling while restoring gut health—positions licorice extract as a potential accessible geroprotector, provided its well-known cardiovascular risks are managed.
Source:
- Open Access Paper: Research on the Antiaging Activity of Licorice Water Extract in Aging Mice via Antioxidation, Neuronal Protection, Gut Microbiota Restoration, and PI3K/AKT/mTOR Modulation
- Date: January 4, 2026 Source: Mediators of Inflammation (Hindawi/Wiley) Institution: College of Pharmacy, Baicheng Medical College & Jilin University, China
- Impact Evaluation: The impact score of Mediators of Inflammation is 4.2 (JIF) , evaluated against a typical high-end range of 0–60+ for top general science. Therefore, this is a Medium impact journal. It is a reputable, peer-reviewed outlet for inflammation and immunology research.
Part 2: The Biohacker Analysis
Study Design Specifications
- Type: In vivo (Animal Study).
-
Subjects: Mice (Strain likely C57BL/6 or KM based on context).
- N-number: 10 per group (Total ~40 mice).
- Groups: Normal Control, D-Galactose (Aging Model), LW1 (Low Dose), LW2 (High Dose).
- Duration: 10 weeks of treatment.
- Lifespan Data: Null. This study utilized a surrogate endpoint model (D-galactose induced senescence) and sacrificed animals to measure biomarkers. It did not measure median or maximum lifespan extension.
Mechanistic Deep Dive
The paper identifies a multi-pronged mechanism that aligns with “Hallmarks of Aging” 3.0:
- mTOR Inhibition (The Heavy Lifter): The study explicitly showed downregulation of p-PI3K, p-AKT, and p-mTOR in brain tissue. This mimics the action of Rapamycin, suggesting licorice acts as a weak mTOR inhibitor, potentially inducing autophagy and clearing protein aggregates in the brain.
- Gut-Brain Axis Restoration: Aging typically spikes the Firmicutes/Bacteroidetes (F/B) ratio, linked to inflammation and obesity. LW treatment significantly lowered this ratio, restoring a “youthful” microbiome profile and increasing beneficial taxa that may produce neuroprotective short-chain fatty acids (SCFAs).
- Senolysis (Partial): The reduction in SA-β-Gal positive cells (senescent cells) in the liver, kidney, and spleen indicates a potential senolytic or senomorphic effect, likely secondary to reduced systemic inflammation (inflammaging).
Novelty
We knew licorice was anti-inflammatory. We didn’t know it systematically downregulates brain mTOR in an aging model. Linking the gut microbiota remodeling directly to this central signaling pathway provides a coherent “gut-brain-aging” loop mechanism for this traditional herb.
Critical Limitations
- The D-Galactose Fallacy: D-galactose creates oxidative stress and damage that looks like aging, but it is not natural chronological aging. Compounds that work here (antioxidants) often fail in natural longevity trials (ITP).
- No Lifespan Data: We have no evidence this extends life, only that it reduces damage markers in a toxicity model.
- Dose Opacity: The abstract and available snippets obscure the exact mg/kg dose used in the final analysis, requiring extrapolation from standard protocols (100–500 mg/kg).
- Translation Risk: The active compound, Glycyrrhizin, has a narrow therapeutic window in humans due to mineralocorticoid side effects (hypertension), which mice handle differently.
Part 3: Actionable Intelligence
The Translational Protocol (Rigorous Extrapolation)
-
Human Equivalent Dose (HED):
- Assumption: Based on standard D-galactose protocols and the “LW2” designation, the high dose is likely 300–500 mg/kg in mice.
- Calculation: Mouse Dose (500 mg/kg) Ă— (3 / 37) = ~40.5 mg/kg Human Dose.
- For a 70kg Adult: ~2,800 mg (2.8g) of Licorice Water Extract per day.
- Note: This is a very high dose for Licorice. A more conservative “biohacker” dose based on the low dose (100 mg/kg) would be ~500–600 mg/day.
-
Pharmacokinetics (PK/PD):
- Bioavailability: Poor oral bioavailability for Glycyrrhizin. It is hydrolyzed by gut bacteria into 18β-glycyrrhetinic acid (the active metabolite), which is well-absorbed.
- Half-Life: Glycyrrhizin has a biphasic elimination; the active metabolite (glycyrrhetinic acid) has a long half-life of 10–30 hours in humans, leading to accumulation with daily dosing.
-
Safety & Toxicity Check:
- Major Hazard: Pseudoaldosteronism. Glycyrrhizin inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This prevents the breakdown of cortisol, allowing cortisol to activate mineralocorticoid receptors.
- Result: Sodium retention, Hypertension (High BP), Hypokalemia (Low Potassium), and edema.
- NOAEL: No established NOAEL for humans, but the European Commission suggests an Upper Limit of 100 mg/day of pure Glycyrrhizin to avoid BP spikes. The extrapolated HED (2.8g extract) likely exceeds this safety limit significantly (depending on % glycyrrhizin, typically 2–10% in extracts).
Biomarker Verification Panel
-
Efficacy Markers:
- hsCRP & IL-6: To verify anti-inflammatory/senomorphic activity.
- HOMA-IR: Improved insulin sensitivity (via PI3K/AKT modulation).
-
Safety Monitoring (MANDATORY):
- Blood Pressure: Daily monitoring is non-negotiable.
- Serum Potassium: Monthly panels to detect hypokalemia (risk of arrhythmia).
- Renin/Aldosterone Ratio: To detect suppression of the renin-angiotensin system.
Feasibility & ROI
-
Sourcing: Licorice Root Extract (Standardized) is widely available (<$15/month).
- Warning: “Deglycyrrhizinated Licorice” (DGL) removes the dangerous component but also removes the component likely responsible for the 11β-HSD2 inhibition and some anti-inflammatory effects. The study used “Water Extract” (containing Glycyrrhizin).
- Cost vs. Effect: Ultra-low cost, but high “metabolic cost” due to side effect management.
- ROI: Low. Better mTOR inhibitors (Rapamycin) exist with cleaner safety profiles when dosed intermittently.
Population Applicability
-
Contraindications: ABSOLUTELY AVOID in anyone with:
- Hypertension (High Blood Pressure).
- History of Arrhythmia (due to K+ risk).
- Renal insufficiency.
- Pregnancy (Glycyrrhizin is associated with developmental issues).
Part 4: The Strategic FAQ
1. Is the “aging” in this study real biological aging?
- No. It is “D-galactose induced senescence.” This mimics oxidative stress and inflammation (inflammaging) but does not replicate the full genomic instability or epigenetic drift of chronological aging.
- Confidence: High
2. Can I use DGL (Deglycyrrhizinated Licorice) to get these benefits without the blood pressure risk?
- Unclear/Unlikely. The study utilized the whole water extract. While flavonoids (glabridin) in DGL have antioxidant properties, Glycyrrhizin itself is a potent anti-inflammatory and is responsible for the systemic hormonal effects. Removing it alters the pharmacology completely.
- Unknown: Specific contribution of Glycyrrhizin vs. Flavonoids to the mTOR effect.
3. Does this interact with Rapamycin?
- Yes. Both inhibit mTOR. Combining them could theoretically cause “mTOR crash” (immune suppression, wound healing issues) or provide additive benefits. Given Licorice’s side effect profile, stacking it with Rapamycin is ill-advised without physician oversight.
4. How does this compare to Metformin?
- Different Mechanism. Metformin primarily activates AMPK (which then inhibits mTOR). Licorice appears to hit the PI3K/AKT upstream of mTOR directly. They could be synergistic, but the hypokalemia risk of Licorice complicates the picture.
5. What is the “kill switch” dose for toxicity?
- In humans, consistent consumption of >50g of black licorice candy (approx. 75-150mg Glycyrrhizin) per day for 2 weeks can cause hospitalization for arrhythmia and hypertension. The “therapeutic” dose in this mouse study is dangerously close to the toxic dose in humans.
6. Did they measure cognitive decline?
- Yes. They used the Morris Water Maze (implied by “behavioral performance” and “hippocampal structure”). The extract preserved spatial memory, likely by preventing neuroinflammation.
7. Why is the gut microbiome finding important?
- The “Firmicutes/Bacteroidetes ratio” increases with age. By lowering it, Licorice mimics the gut profile of a younger/leaner animal. This suggests it might help with “age-related weight gain” (which the study confirmed it reversed).
8. Is this compound bioavailable in the brain?
- Debatable. Glycyrrhizin itself crosses the blood-brain barrier poorly. However, its metabolites (glycyrrhetinic acid) or the flavonoids (liquiritigenin) can cross. The observed brain effects may be downstream of systemic inflammation reduction rather than direct brain target engagement.
9. Can I take this if I am on blood pressure medication?
- NO. Licorice can antagonize the effects of antihypertensives (making them stop working) and can cause dangerous potassium drops when combined with diuretics (hydrochlorothiazide, furosemide).
10. What is the single most critical missing piece of data?
- Lifespan Survival Curves. Without showing that these mice actually lived longer, we only know they “looked” better while they were alive on the drug.
Conflicts Check:
- Rapamycin: Additive mTOR inhibition risk.
- Diuretics (Thiazides/Loop): MAJOR CONFLICT. High risk of severe hypokalemia.
- Corticosteroids: Potentiation of steroid effects (Licorice slows cortisol breakdown).
- Digoxin: Hypokalemia increases risk of digoxin toxicity.